John Hart

16.3k total citations
329 papers, 8.8k citations indexed

About

John Hart is a scholar working on Surgery, Oncology and Epidemiology. According to data from OpenAlex, John Hart has authored 329 papers receiving a total of 8.8k indexed citations (citations by other indexed papers that have themselves been cited), including 113 papers in Surgery, 65 papers in Oncology and 62 papers in Epidemiology. Recurrent topics in John Hart's work include Genetic factors in colorectal cancer (27 papers), Inflammatory Bowel Disease (24 papers) and Gastric Cancer Management and Outcomes (24 papers). John Hart is often cited by papers focused on Genetic factors in colorectal cancer (27 papers), Inflammatory Bowel Disease (24 papers) and Gastric Cancer Management and Outcomes (24 papers). John Hart collaborates with scholars based in United States, Australia and Canada. John Hart's co-authors include Marc Bissonnette, David T. Rubin, Amy Noffsinger, Irving Waxman, Vani J. Konda, Donald M. Jensen, Jerrold R. Turner, Shu‐Yuan Xiao, Mitchell C. Posner and Maria Tretiakova and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

John Hart

305 papers receiving 8.6k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
John Hart 2.8k 2.1k 2.0k 1.7k 1.5k 329 8.8k
Hyun Soo Kim 2.6k 1.0× 1.9k 0.9× 1.9k 0.9× 4.0k 2.4× 1.7k 1.2× 653 12.9k
Michael Gregor 1.6k 0.6× 1.0k 0.5× 1.3k 0.7× 2.7k 1.6× 982 0.7× 200 7.7k
James M. Crawford 2.9k 1.0× 2.3k 1.1× 1.7k 0.8× 1.9k 1.1× 1.2k 0.8× 201 10.9k
Daniel Candinas 5.4k 1.9× 909 0.4× 1.2k 0.6× 1.5k 0.9× 1.3k 0.9× 357 10.0k
Hisashi Yamanaka 2.1k 0.8× 2.6k 1.2× 1.3k 0.6× 2.7k 1.6× 1.8k 1.2× 739 17.7k
Kenneth K. Tanabe 1.9k 0.7× 2.6k 1.2× 4.4k 2.1× 3.2k 1.9× 2.0k 1.4× 236 11.6k
Tao Li 1.5k 0.6× 1.4k 0.6× 2.1k 1.0× 3.4k 2.1× 1.3k 0.9× 614 9.3k
Eric Van Marck 927 0.3× 2.1k 1.0× 2.7k 1.3× 2.4k 1.5× 1.5k 1.0× 205 9.0k
Chyong‐Huey Lai 2.3k 0.8× 3.2k 1.5× 1.7k 0.8× 1.5k 0.9× 956 0.6× 381 10.4k
Alexander Stojadinovic 4.4k 1.6× 1.0k 0.5× 3.6k 1.8× 2.3k 1.4× 2.5k 1.7× 257 12.5k

Countries citing papers authored by John Hart

Since Specialization
Citations

This map shows the geographic impact of John Hart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Hart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Hart more than expected).

Fields of papers citing papers by John Hart

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Hart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Hart. The network helps show where John Hart may publish in the future.

Co-authorship network of co-authors of John Hart

This figure shows the co-authorship network connecting the top 25 collaborators of John Hart. A scholar is included among the top collaborators of John Hart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Hart. John Hart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shah, Bhavesh, Rickard Sandin, Yun Liu, et al.. (2025). Economic Impact of Elranatamab for Treatment of Patients with Relapsed or Refractory Multiple Myeloma. ClinicoEconomics and Outcomes Research. Volume 17. 289–302.
2.
Setia, Namrata, Daniela del Gaudio, Kelly Arndt, et al.. (2023). A novel telomere biology disease‐associated gastritis identified through a whole exome sequencing‐driven approach. The Journal of Pathology Clinical Research. 10(1). e349–e349. 1 indexed citations
3.
Marcus, Victoria, et al.. (2023). Portosinusoidal Vascular Disorder: A Heretofore Unrecognized Manifestation of Sickle Cell Disease?. Modern Pathology. 37(1). 100351–100351. 2 indexed citations
4.
Brown, Ian, Stephen M. Lagana, Maria Westerhoff, et al.. (2022). The histological spectrum of ARB‐induced gastritis. Histopathology. 81(5). 653–660. 5 indexed citations
5.
Adair, Tim, L. L. Mikkelsen, Pasyodun Koralage Buddhika Mahesh, et al.. (2021). The impact of errors in medical certification on the accuracy of the underlying cause of death. SHILAP Revista de lepidopterología.
6.
Pytel, Peter, Heather L. Smith, Robert D. Guzy, et al.. (2021). A series of COVID‐19 autopsies with clinical and pathologic comparisons to both seasonal and pandemic influenza. The Journal of Pathology Clinical Research. 7(5). 459–470. 9 indexed citations
7.
Siddiqui, Uzma D., et al.. (2021). Endoscopic submucosal dissection for colorectal lesions: outcomes from a United States experience. Surgical Endoscopy. 36(1). 236–243. 9 indexed citations
8.
Christensen, Britt, Stephen B. Hanauer, Peter G. Gibson, et al.. (2020). Segmental Histological Normalisation Occurs in Ulcerative Colitis but Does Not Improve Clinical Outcomes. Journal of Crohn s and Colitis. 14(10). 1345–1353. 12 indexed citations
9.
Dougherty, Urszula, Reba Mustafi, Jeffrey S. Souris, et al.. (2019). Losartan and Vitamin D Inhibit Colonic Tumor Development in a Conditional Apc-Deleted Mouse Model of Sporadic Colon Cancer. Cancer Prevention Research. 12(7). 433–448. 3 indexed citations
10.
Maron, Steven B., Lindsay Alpert, Heewon Kwak, et al.. (2018). Targeted Therapies for Targeted Populations: Anti-EGFR Treatment for EGFR -Amplified Gastroesophageal Adenocarcinoma. Cancer Discovery. 8(6). 696–713. 79 indexed citations
11.
Foster, Corey C., Larissa V. Furtado, John Hart, et al.. (2018). Treatment outcomes and HPV characteristics for an institutional cohort of patients with anal cancer receiving concurrent chemotherapy and intensity-modulated radiation therapy. PLoS ONE. 13(3). e0194234–e0194234. 6 indexed citations
12.
Pekow, Joel, Katherine Meckel, Urszula Dougherty, et al.. (2017). miR-193a-3p is a Key Tumor Suppressor in Ulcerative Colitis–Associated Colon Cancer and Promotes Carcinogenesis through Upregulation of IL17RD. Clinical Cancer Research. 23(17). 5281–5291. 72 indexed citations
13.
Mustafi, Reba, Urszula Dougherty, Devkumar Mustafi, et al.. (2016). ADAM17 is a Tumor Promoter and Therapeutic Target in Western Diet–associated Colon Cancer. Clinical Cancer Research. 23(2). 549–561. 36 indexed citations
14.
Dougherty, Urszula, Reba Mustafi, Devkumar Mustafi, et al.. (2014). The Renin–Angiotensin System Mediates EGF Receptor–Vitamin D Receptor Cross-Talk in Colitis-Associated Colon Cancer. Clinical Cancer Research. 20(22). 5848–5859. 36 indexed citations
15.
Dougherty, Urszula, Victoria Robinson, Reba Mustafi, et al.. (2011). EGFR Signals Downregulate Tumor Suppressors miR-143 and miR-145 in Western Diet–Promoted Murine Colon Cancer: Role of G1 Regulators. Molecular Cancer Research. 9(7). 960–975. 96 indexed citations
16.
Dougherty, Urszula, Masha Kocherginsky, Amikar Sehdev, et al.. (2009). Epidermal Growth Factor Receptor Is Required for Colonic Tumor Promotion by Dietary Fat in the Azoxymethane/Dextran Sulfate Sodium Model: Roles of Transforming Growth Factor- and PTGS2. Clinical Cancer Research. 15(22). 6780–6789. 30 indexed citations
17.
Dougherty, Urszula, Amikar Sehdev, Sandra Cerda, et al.. (2008). Epidermal Growth Factor Receptor Controls Flat Dysplastic Aberrant Crypt Foci Development and Colon Cancer Progression in the Rat Azoxymethane Model. Clinical Cancer Research. 14(8). 2253–2262. 48 indexed citations
18.
Fichera, Alessandro, Sujatha Jagadeeswaran, Urszula Dougherty, et al.. (2007). Epidermal Growth Factor Receptor Signaling Is Required for Microadenoma Formation in the Mouse Azoxymethane Model of Colonic Carcinogenesis. Cancer Research. 67(2). 827–835. 47 indexed citations
19.
Posner, Mitchell C., James O. Park, Thomas E. Darga, et al.. (2005). Progression of Barrett's Metaplasia to Adenocarcinoma Is Associated with the Suppression of the Transcriptional Programs of Epidermal Differentiation. Cancer Research. 65(8). 3146–3154. 133 indexed citations
20.
Carmichael, Amtul R., David A. Johnston, John Hart, et al.. (1996). Audit and inflammatory bowel disease. Gut. 39(Suppl 1). A35–A37. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hyun Soo Kim Breakdown of academic impact, for papers by Michael Gregor Breakdown of academic impact, for papers by James M. Crawford Breakdown of academic impact, for papers by Daniel Candinas Breakdown of academic impact, for papers by Hisashi Yamanaka Breakdown of academic impact, for papers by Kenneth K. Tanabe Breakdown of academic impact, for papers by Tao Li Breakdown of academic impact, for papers by Eric Van Marck Breakdown of academic impact, for papers by Chyong‐Huey Lai Breakdown of academic impact, for papers by Alexander Stojadinovic
Rankless by CCL
2026